pharma news
Shingrix Granted Approval by Japan’s Ministry of Health Labour and Welfare for Shingles Prevention in At-Risk Individuals 18 Years and Older
Source – GSK On 26 June 2023, GSK announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has ...
VCN-01 Plus Chemotherapy Receives FDA Orphan Drug Designation for Early PDAC Treatment
Source – Theriva Biologics On 28June 2023, the FDA has granted Orphan Drug Designation (ODD) to VCN-01 in combination with ...
Bellus Health Acquired by GSK is complete
Source – GSK On 28 June 2023, GSK and BELLUS Health announced the completion of GSK’s acquisition of BELLUS through ...
As a result of production issues, the FDA rejected Eton Pharma’s proposed therapy for methanol poisoning
Source – Eton Pharmaceuticals Eton Pharmaceuticals’ dehydrated alcohol injection did not receive approval from the FDA and instead received a ...
Reata Pharmaceuticals Begins Launching Its First Commercial Product Skyclarys with Approved Supplement
Source – Reata Pharmaceuticals After receiving approval in the spring, Reata Pharmaceuticals has been eagerly awaiting the launch of its ...
Investor NexPoint has threatened to prevent the $462 million sale of Paratek
Source – Paratek Pharmaceuticals On 29 June, Paratek Pharmaceuticals is scheduled to hold its annual meeting, but a contentious situation ...
Dementia Solutions: Eisai, Gates, UK Health & Univ. Edinburgh
Source – Eisai On June 29, 2023, Eisai, Gates Ventures, Health Data Research UK, LifeArc, and The University of Edinburgh ...
Real Testimonials from Families Affected by CMV: Taking Action and Raising Awareness
Source – Moderna In 2011, Ayako Kamei, a Principal Scientist at Moderna Enzymatics, experienced the joy of welcoming her second ...
The pipeline for RSV, influenza, meningitis, and pneumococcal disease vaccines raises the bar
Source – Sanofi On June 29, 2023, Sanofi is hosting an investor event focused on its Vaccines pipeline, featuring key ...
Pediatric Growth Hormone Deficiency Long-Acting Once-Weekly Treatment NGENLA by Pfizer Receives FDA Approval
Source – Pfizer On 29 June 2023, Pfizer and OPKO Health jointly announced that the US Food and Drug Administration ...
Combining mitazalimab with chemotherapy demonstrates significant antitumor activity in metastatic pancreatic ductal adenocarcinoma
Source – Alligator Bioscience On June 26, 2023 the combination of mitazalimab, a novel CD40 monoclonal antibody agonist, with chemotherapy ...
Initiation of Treatment with TTI-101, Either Alone or in Combination with Standard Targeted Therapy, in Advanced Hepatocellular Carcinoma
Source – Tvardi Therapeutics On June 22, 2023 the initial administration of TTI-101, either as a monotherapy or in combination ...
National Institute for Health and Care Excellence remains skeptical about the effectiveness of Mounjaro for diabetes
Eli Lilly has received positive data for its experimental obesity therapies, but in the UK, it faced a setback as ...
A recent study demonstrates the efficacy of the digital Dario tool in managing severe diabetes
Source – DarioHealth A joint effort between DarioHealth and Sanofi has yielded promising results in a real-world study presented at ...
The FDA expedites the development of GSK’s vaccine for gonorrhea
Source – GSK GSK’s vaccine for gonorrhea has received a fast-track designation from the FDA, signaling its potential to combat ...
UCB has achieved a long-awaited victory as the FDA grants approval for the myasthenia gravis drug Rystiggo
Source – UCB On 27 June 2023, UCB faced regulatory challenges in the United States for the second consecutive year, ...
AstraZeneca Invests $400M in Reforestation and Biodiversity
Source – AstraZeneca AstraZeneca has made a significant announcement of a $400 million investment in its global AZ Forest program, ...
